Altered Habenula Activity following Ketamine Administration in Treatment-Resistant Major Depression

被引：0
|
作者：
Carlson, Paul J. [1 ,2 ]
DiazGranados, Nancy [3 ]
Nugent, Allison [4 ]
Ibrahim, Lobna [4 ]
Luckenbaugh, David [4 ]
Tinsley, Ruth [4 ]
Brutsche, Nancy [4 ]
Herscovitch, Peter [5 ]
Manji, Husseini K. [6 ,7 ]
Zarate, Carlos A. [4 ]
Drevets, Wayne C. [8 ]
机构：
[1] Salt Lake VAMC, Salt Lake City, UT USA
[2] Univ Utah, Sch Med, Salt Lake City, UT USA
[3] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[4] NIMH, Expt Therapeut & Pathophysiol Branch, DIRP, NIH, Bethesda, MD 20892 USA
[5] NIH, Positron Emiss Tomog Dept, Ctr Clin, Bethesda, MD 20892 USA
[6] CNS, Titusville, NJ USA
[7] Pain Johnson & Johnson, Titusville, NJ USA
[8] Univ Oklahoma, Laureate Inst Brain Res, Coll Med, Tulsa, OK USA
来源：
BIOLOGICAL PSYCHIATRY | 2011年 / 69卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
537
引用
收藏
页码：160S / 161S
页数：2
相关论文
共 50 条
  • [21] Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
    Pastuszak, Michal
    Cubala, Wieslaw Jerzy
    Kwasny, Aleksander
    [J]. DRUGS-REAL WORLD OUTCOMES, 2024,
  • [22] Functionally altered neurocircuits in a rat model of treatment-resistant depression show prominent role of the habenula
    Gass, Natalia
    Cleppien, Dirk
    Zheng, Lei
    Schwarz, Adam James
    Meyer-Lindenberg, Andreas
    Vollmayr, Barbara
    Weber-Fahr, Wolfgang
    Sartorius, Alexander
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (03) : 381 - 390
  • [23] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    [J]. Psychopharmacology, 2014, 231 : 481 - 488
  • [24] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
  • [25] Regulation of Neural Responses to Emotion by Ketamine in Individuals with Treatment-resistant Major Depression
    Murrough, James
    Collins, Katherine
    Fields, Jessica
    Dewilde, Kaitlin
    Phillips, Mary
    Mathew, Sanjay
    Wong, Edmund
    Tang, Cheuk
    Charney, Dennis
    Iosifescu, Dan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S554 - S554
  • [26] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [27] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [28] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [29] Comparative Efficacy of Ketamine in Treatment-Resistant Depression
    Kurt, Hatice Guncu
    Altinay, Murat
    Anand, Amit
    [J]. PSYCHIATRIC ANNALS, 2020, 50 (02) : 62 - 67
  • [30] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
12345